NCT03737110Phase 3Completed

Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis

Study sponsor: Kiniksa Pharmaceuticals (UK), Ltd.

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2020-05-29Actual
Enrollment · participants86Actual
Source updated2023-09-06Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.